Produkty 63335-25-1

CAS 63335-25-1 występuje w naszej ofercie pod nazwami: Malabaricone C, Malabaricone C, Malabaricone C/ 99.48% (existing batch purity), Malabaricone C 97%, Malabaricone C, 99.46%. Oferty producentów: GLPBio, TRC, TargetMol, Biosynth, Ambeed. Dostępne opakowania: 1mg, 100mg, 10mg, 5mg, 25mg, 50mg, 2mg, 10 mg.

Malabaricone C
GLPBio
  • opakowanie: 1mg, 10mg, 5mg
  • Warianty: 3
od 667,25
Zobacz produkt
Malabaricone C
TRC, Biosynth, Chemat
  • opakowanie: 100mg, 1mg, 2mg, 5mg
  • Warianty: 9
od 395,60
Zobacz produkt
Malabaricone C/ 99.48% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 5
od 731,05
Zobacz produkt
Malabaricone C 97%
Ambeed
  • opakowanie: 1mg, 5mg, 10mg, 50mg
  • Warianty: 4
od 381,50
Zobacz produkt
Malabaricone C, 99.46%
MedChemExpress
  • opakowanie: 10 mg, 5 mg, 10mM/1mL, 1 mg
  • Warianty: 4
od 407,93
Zobacz produkt
Malabaricone C (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one (CAS 63335-25-1) to związek chemiczny o wzorze sumarycznym C21H26O5 i masie molowej 358.4 g/mol. Nazwa systematyczna IUPAC: 1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one. InChIKey: HCOZRFYGIFMIEX-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H26O5
Masa molowa358.4 g/mol
Nazwa IUPAC1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one
InChIKeyHCOZRFYGIFMIEX-UHFFFAOYSA-N
SMILESC1=CC(=C(C(=C1)O)C(=O)CCCCCCCCC2=CC(=C(C=C2)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Malabaricone C, 1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)nonan-1-one, 1-Nonanone, 1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)-, 1-(2,6-dihydroxyphenyl)-9-(3,4-dihydroxyphenyl)-1-nonanone, MEGxp0_000379, orb1217787, orb1296979, Malabaricone C, 10 mM in DMSO, 1-(2,6-Bis(oxidanyl)phenyl)-9-(3,4-bis(oxidanyl)phenyl)nonan-1-one
Izomery (ten sam wzór sumaryczny)
3-[4-[2-[4-(oxiran-2-ylmethoxy)phenyl]propan-2-yl]phenoxy]propane-1,2-diol C21H26O5
(1S,2S,4R,6S,7S,9S,10S,11R)-9-hydroxy-6-(2-hydroxyacetyl)-7,11-dimethyl-5-oxapentacyclo[8.8.0.02,7.04,6.011,16]octadeca-12,15-dien-14-one C21H26O5
(8S,10S,13S,14S,16R,17S)-16,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,12,14,15,16-hexahydro-6H-cyclopenta[a]phenanthren-3-one C21H26O5
(3S,3aR,9aR)-3-hexanoyl-9a-methyl-6-[(E)-prop-1-enyl]-3,3a,4,8-tetrahydrofuro[3,2-g]isochromene-2,9-dione C21H26O5
(1S,2S,4R,8S,9S,11S,12S,13R)-6,11-dihydroxy-9,13-dimethyl-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-7,16-dione C21H26O5
(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one C21H26O5
(1S,2S,10S,11S,14R,15S,17S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyl-18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadeca-3,6-dien-5-one C21H26O5
2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde C21H26O5
(8S,9S,10R,11R,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-9,11,12,14,15,16-hexahydro-8H-cyclopenta[a]phenanthren-3-one C21H26O5
2-[(8S,9S,10R,13S,14S,17R)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,6,7,8,9,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoacetaldehyde C21H26O5
(8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione C21H26O5
9-(4-hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)nonan-1-one C21H26O5